Contract HHSN275201700263P
Enzo Life Sciences, Inc · Department Of Health And Human Services · March 3, 2017
Enzo Life Sciences, Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on March 3, 2017 for $9,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Farmingdale, NY. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 7, 2021.
Contract details
- PIID
- HHSN275201700263P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Farmingdale, NY
- First action
- March 3, 2017
- Latest action
- October 7, 2021
Description
HIGH SENSITIVITY ELISA KIT
Modification timeline
-
October 7, 2021Mod P00001$-83
-
March 3, 2017Base awardIGF::OT::IGF - ENZO LIFE SCIENCES INTERNATIONAL, INC.:1145101 [17-005500]$8.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN275201700263P?
Contract HHSN275201700263P is a federal contract awarded to Enzo Life Sciences, Inc by Department Of Health And Human Services on March 3, 2017 for $9,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSN275201700263P?
Enzo Life Sciences, Inc won contract HHSN275201700263P from Department Of Health And Human Services.
How much is contract HHSN275201700263P worth?
Contract HHSN275201700263P has obligated $9,000 to date.